Progress in antenatal magnesium sulfate exposure for neuroprotection in preterm infants / 中华围产医学杂志
Chinese Journal of Perinatal Medicine
; (12): 68-71, 2023.
Article
em Zh
| WPRIM
| ID: wpr-995066
Biblioteca responsável:
WPRO
ABSTRACT
Magnesium sulfate has been administered to pregnant women at imminent risk of preterm delivery for fetal neuroprotection, but its adverse effects and target population have not been fully studied. This paper summarizes the current protocols according to the existing guidelines and the latest research progress, including the gestational age at intervention, dose, duration of therapy and the need for re-administration, hoping to provide a reference for the clinical use of magnesium sulfate for fetal neuroprotection in China.
Texto completo:
1
Base de dados:
WPRIM
Idioma:
Zh
Ano de publicação:
2023
Tipo de documento:
Article